[
  "2025-04-30 12-29_Johnson & Johnson receives FDA approval for IMAAVY™ (nipocalimab-aahu), a new FcRn blocker offering .txt",
  "2025-04-30 17-30_Johnson & Johnson (NYSE_JNJ) Gains FDA Approval For IMAAVY™ To Treat Myasthenia Gravis.txt",
  "2025-04-30 18-28_Is Johnson & Johnson (JNJ) the Best Dow Stock for the Next 12 Months_.txt",
  "2025-04-30 20-17_Johnson & Johnson (JNJ)_ Jim Cramer Says “They Love the Weak Dollar” — Is This Quiet Giant Back in F.txt",
  "2025-04-30 21-02_Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems.txt",
  "2025-05-01 01-48_Trump Says Tariffs Politically Risky, But He’s Not Rushing Deals.txt",
  "2025-05-01 08-49_The Zacks Analyst Blog Highlights Amazon, Johnson & Johnson, Cisco Systems and NeurAxis.txt",
  "2025-05-01 10-40_FDA approves J&J’s Imaavy for generalised myasthenia gravis.txt",
  "2025-05-01 12-00_If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again_.txt",
  "2025-05-01 12-24_Pharma downplays tariff threat, even as risks remain unclear.txt",
  "2025-05-01 16-06_'Declare victory and move on'_ Eli Lilly CEO on Trump tariff threat.txt",
  "2025-05-02 15-06_Q1 earnings pulse check_ companies tentative on pharma-specific tariffs.txt"
]